Sigma Of Australia Names Former CFO As New CEO
This article was originally published in PharmAsia News
Executive Summary
Australia's Sigma Pharmaceuticals named Mark Hooper, a former CFO, to serve as its new CEO and managing director, effective in September
Australia's Sigma Pharmaceuticals named Mark Hooper, a former CFO, to serve as its new CEO and managing director, effective in September. Chairman John Stocker said the naming of Hooper would give the beleagured company a CEO with a strong knowledge of the company and pharmaceutical industry to lead the firm's next development phase. Hooper was Sigma CFO from 2001-2006 before leaving to serve in same job with PaperlinX. (Click here for more) "Sigma Names Hooper As New CEO" - Business Day (6/16/10) |